Company Filing History:
Years Active: 2008
Title: **Innovator Spotlight: Tatsuaki Miyaji**
Introduction
Tatsuaki Miyaji, an accomplished inventor based in Osaka, Japan, has made significant contributions to the field of pharmaceuticals. His innovative work focuses on creating advanced drug delivery systems that enhance the efficacy and reliability of medication.
Latest Patents
One of Tatsuaki Miyaji's notable patents is a bioabsorbable pharmaceutical formulation. This formulation utilizes a biodegradable release-sustaining base material designed to regulate the release of an effective component drug. The technology ensures that the drug is not released too rapidly after administration, allowing for a sustained release over a period of at least one month at a defined rate. The biodegradable release-sustaining base material employed in this formulation is a lactic acid-glycolic acid copolymer (PLGA) with an optimally adjusted distribution in molecular weight.
Career Highlights
Tatsuaki Miyaji is associated with Nipro Corporation, a leading company in the pharmaceutical and medical devices sector. His work there reflects his commitment to developing innovative solutions that address contemporary healthcare challenges. His expertise in bioabsorbable materials has positioned him as a notable figure within the industry.
Collaborations
Throughout his career, Tatsuaki has collaborated with talented individuals such as Makoto Sato and Tamaki Murayama. These partnerships amplify the impact of his innovations and contribute to the development of pioneering technologies within the pharmaceutical field.
Conclusion
Tatsuaki Miyaji's contributions to the field of pharmaceuticals through his innovative patent signify an advancement in drug delivery systems. By merging biodegradable materials with effective drug release mechanisms, he plays a critical role in shaping the future of medication administration. His work exemplifies the spirit of innovation that drives progress in healthcare.